Client Background:
A global provider of surgical microscopy solutions operating in a capital expenditure (CapEx)-driven market, seeking flexible pricing models to improve affordability, strengthen hospital ROI justification, and expand revenue opportunities.
Challenges:
- Limited recurring revenue opportunities beyond equipment sales and service contracts.
- Emerging robotics pricing models creating potential disruption risks and cross-industry learning opportunities.
- Uncertainty around hospital willingness to adopt alternative pricing and financing models.
- Need to balance commercial viability, hospital affordability, and adoption barriers.
Engagement Objective:
The engagement aimed to benchmark innovative pricing models in surgical robotics and assess their applicability to surgical microscopy, identifying scalable strategies to expand revenue, improve accessibility, and strengthen customer engagement.
Approach:
The study followed a structured secondary and primary research approach to assess pricing innovation opportunities and their applicability to surgical microscopy. Our team:
- Mapped robotics OEM pricing models, including subscriptions, pay-per-use, and AI-enabled add-ons.
- Interviewed surgeons, KOLs, and hospital procurement stakeholders to understand adoption drivers and barriers.
- Surveyed hospitals to evaluate willingness to adopt alternative pricing and financing models.
- Evaluated commercial feasibility, scalability, and portfolio applicability.
- Prioritized pricing and financing opportunities through a risk-benefit assessment.
Solutions Offered:
- Comparative landscape of emerging pricing and engagement models across surgical robotics OEMs.
- Assessment of the applicability and feasibility of alternative commercial models for surgical microscopy.
- Stakeholder insights into hospital purchasing preferences, adoption drivers, and barriers to implementation.
- Hospital willingness-to-adopt assessment to inform prioritization of alternative pricing and financing approaches.
- Prioritized pricing and financing strategy playbook supported by a risk-benefit assessment.
- Identification of potential co-business opportunities through stakeholder engagement with surgical robotics OEMs.
Client Impact:
- Established an evidence-based roadmap for pricing innovation and revenue diversification.
- Identified opportunities to improve hospital accessibility while addressing adoption risks.
- Supported exploration of recurring revenue streams and flexible commercial models.
- Enabled stakeholder engagement with robotics OEMs to explore co-business opportunities.
- Strengthened competitive positioning as a flexible, innovation-led commercial partner.
Outcome Snapshot:
